Ｐ３００／ＣＢＰＨＡＴ阻害剤及びその使用方法

Title:

Ｐ３００／ＣＢＰＨＡＴ阻害剤及びその使用方法

Document Type and Number:

Japanese Patent JP2022522349

Kind Code:

A

Abstract:

式（Ｉ）の化合物TIFF2022522349000065.tif2176ならびにその医薬的に許容される塩及び組成物が提供される。これらは、ヒストンアセチルトランスフェラーゼ（ＨＡＴ）に関連する様々な状態の治療に有用である。【選択図】なし

More Like This:

WO/2019/204550	ISOINDOLINES AS HDAC INHIBITORS
JP3288132	SUBSTITUTED 1,2,4-TRIAZINE-3,5-DIONE AND ANTICOCCIDIAL COMPOSITION CONTAINING THE COMPOUND AS ACTIVE COMPONENT
JP2023520006	N-(Heterocyclyl and heterocyclylalkyl)-3-benzylpyridin-2-amine derivatives as SSTR4 agonists

Inventors:

Wilson, Jonathan Yee

Application Number:

JP2021550155A

Publication Date:

April 18, 2022

Filing Date:

February 26, 2020

Export Citation:

Click for automatic bibliography generation Help

Assignee:

CONSTELLATION PHARMACEUTICALS,INC.

International Classes:

C07D401/12; A61K31/4427; A61K31/443; A61K31/4433; A61K31/4439; A61K31/4545; A61K31/513; A61P1/04; A61P1/16; A61P3/00; A61P3/04; A61P3/06; A61P3/10; A61P9/00; A61P9/12; A61P11/00; A61P11/06; A61P13/12; A61P17/00; A61P17/06; A61P25/28; A61P29/00; A61P31/12; A61P33/02; A61P35/00; A61P35/02; C07D405/12; C07D413/12

Attorney, Agent or Firm:

Osamu Yamamoto
Toru Miyamae
Junichi Matsuo
Tsurukuro Toshitaka

Previous Patent: Equipment and methods for inspecting membranes on substrates

Next Patent: Attenuated salmonella.Tiffimurium(Salmonella typhimurium)Treatment of benign nervous system tumors ...